glp-1 pancreatitis law firm in louisiana What You Need to Know About Drug Injury Will Louisiana Blue Pay for

Description

Since obesity, insulin resistance, liver fat, and metabolic dysfunction are closely linked, GLP-1 and glucagon-based combinations are being studied for their potential to reduce liver fat, improve metabolic markers, and slow disease progression

Other Potential Effects: Temporary fatigue during adjustment period (usually improves after 2-4 weeks) Headaches, typically mild and resolving without intervention Injection site reactions for injectable formulations (redness, mild irritation) Dizziness, particularly if inadequate caloric or fluid intake Changes in taste perception or food preferences When to Contact Medical Team Immediately: Patients should seek immediate medical guidance if experiencing: Severe abdominal pain that doesn't resolve, particularly radiating to the back Vision changes, eye pain, or sudden vision disturbances Signs of pancreatitis: severe persistent stomach pain, nausea, vomiting Symptoms of gallbladder issues: right upper abdominal pain, jaundice, clay-colored stools Severe persistent nausea or vomiting causing dehydration or inability to keep fluids down Thoughts of self-harm, severe depression, or significant mood changes Allergic reactions: rash, itching, swelling, difficulty breathing Signs of kidney problems: decreased urination, swelling, unusual fatigue Serious Side Effects Disclaimer: While rare, GLP-1 medications carry potential risks including pancreatitis, gallbladder disease (cholecystitis, cholelithiasis), acute kidney injury, severe hypoglycemia when combined with other diabetes medications, thyroid C-cell tumors, and allergic reactions